Market Research Logo

HIV / AIDS - Pipeline Review, H1 2015

HIV / AIDS - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for HIV / AIDS, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV / AIDS and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of HIV / AIDS
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for HIV / AIDS and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the HIV / AIDS products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the HIV / AIDS pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for HIV / AIDS
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding HIV / AIDS pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
HIV / AIDS Overview
Therapeutics Development
HIV / AIDS - Therapeutics under Development by Companies
HIV / AIDS - Therapeutics under Investigation by Universities/Institutes
HIV / AIDS - Pipeline Products Glance
HIV / AIDS - Products under Development by Companies
HIV / AIDS - Products under Investigation by Universities/Institutes
HIV / AIDS - Companies Involved in Therapeutics Development
HIV / AIDS - Therapeutics Assessment
Drug Profiles
HIV / AIDS - Recent Pipeline Updates
HIV / AIDS - Dormant Projects
HIV / AIDS - Discontinued Products
HIV / AIDS - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for HIV / AIDS, H1 2015
Number of Products under Development for HIV / AIDS - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Development by Companies, H1 2015 (Contd..7)
Number of Products under Development by Companies, H1 2015 (Contd..8)
Number of Products under Development by Companies, H1 2015 (Contd..9)
Number of Products under Development by Companies, H1 2015 (Contd..10)
Number of Products under Development by Companies, H1 2015 (Contd..11)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..5)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Development by Companies, H1 2015 (Contd..9)
Products under Development by Companies, H1 2015 (Contd..10)
Products under Development by Companies, H1 2015 (Contd..11)
Products under Development by Companies, H1 2015 (Contd..12)
Products under Development by Companies, H1 2015 (Contd..13)
Products under Development by Companies, H1 2015 (Contd..14)
Products under Development by Companies, H1 2015 (Contd..15)
Products under Development by Companies, H1 2015 (Contd..16)
Products under Development by Companies, H1 2015 (Contd..17)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..5)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..6)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..7)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..8)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..9)
HIV / AIDS - Pipeline by Abivax S.A., H1 2015
HIV / AIDS - Pipeline by Adaptimmune Limited, H1 2015
HIV / AIDS - Pipeline by AiCuris GmbH & Co. KG, H1 2015
HIV / AIDS - Pipeline by Akshaya Bio Inc., H1 2015
HIV / AIDS - Pipeline by AlphaVax, Inc., H1 2015
HIV / AIDS - Pipeline by Altor BioScience Corporation, H1 2015
HIV / AIDS - Pipeline by AltraVax Inc., H1 2015
HIV / AIDS - Pipeline by Amarna Therapeutics B.V., H1 2015
HIV / AIDS - Pipeline by American Gene Technologies International Inc., H1 2015
HIV / AIDS - Pipeline by Amplyx Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Antigen Express, Inc., H1 2015
HIV / AIDS - Pipeline by Aphios Corporation, H1 2015
HIV / AIDS - Pipeline by Argos Therapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by Astex Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Avexa Limited, H1 2015
HIV / AIDS - Pipeline by BCI Pharma, H1 2015
HIV / AIDS - Pipeline by BioClonetics Immunotherapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by Bionor Pharma ASA, H1 2015
HIV / AIDS - Pipeline by Biosantech SA, H1 2015
HIV / AIDS - Pipeline by Biotron Limited, H1 2015
HIV / AIDS - Pipeline by Boehringer Ingelheim GmbH, H1 2015
HIV / AIDS - Pipeline by Bristol-Myers Squibb Company, H1 2015
HIV / AIDS - Pipeline by C4X Discovery Limited, H1 2015
HIV / AIDS - Pipeline by Calimmune, Inc., H1 2015
HIV / AIDS - Pipeline by Celldex Therapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by CompleGen, Inc., H1 2015
HIV / AIDS - Pipeline by Critical Outcome Technologies Inc., H1 2015
HIV / AIDS - Pipeline by CureVac GmbH, H1 2015
HIV / AIDS - Pipeline by CytoDyn Inc., H1 2015
HIV / AIDS - Pipeline by DNAVEC Corporation, H1 2015
HIV / AIDS - Pipeline by Enzo Biochem, Inc., H1 2015
HIV / AIDS - Pipeline by EpiVax, Inc., H1 2015
HIV / AIDS - Pipeline by Etubics Corporation, H1 2015
HIV / AIDS - Pipeline by Farmsintez, H1 2015
HIV / AIDS - Pipeline by FIT Biotech Oy, H1 2015
HIV / AIDS - Pipeline by Fountain Biopharma Inc., H1 2015
HIV / AIDS - Pipeline by Frontier Biotechnologies Co., Ltd, H1 2015
HIV / AIDS - Pipeline by GeneCure LLC, H1 2015
HIV / AIDS - Pipeline by Genetic Immunity, Inc, H1 2015
HIV / AIDS - Pipeline by Genticel S.A., H1 2015
HIV / AIDS - Pipeline by GeoVax Labs, Inc., H1 2015
HIV / AIDS - Pipeline by Gilead Sciences, Inc., H1 2015
HIV / AIDS - Pipeline by GlaxoSmithKline Plc, H1 2015
HIV / AIDS - Pipeline by Globeimmune, Inc., H1 2015
HIV / AIDS - Pipeline by Hadasit Medical Research Services & Development Ltd, H1 2015
HIV / AIDS - Pipeline by Heat Biologics, Inc., H1 2015
HIV / AIDS - Pipeline by Heptares Therapeutics Limited, H1 2015
HIV / AIDS - Pipeline by Hetero Drugs Limited, H1 2015
HIV / AIDS - Pipeline by Humabs BioMed SA, H1 2015
HIV / AIDS - Pipeline by iCo Therapeutics Inc., H1 2015
HIV / AIDS - Pipeline by Immune Response BioPharma, Inc., H1 2015
HIV / AIDS - Pipeline by Immunocore Limited, H1 2015
HIV / AIDS - Pipeline by ImmunoGenetix Therapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by Immunomic Therapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by Immunotech Laboratories, Inc., H1 2015
HIV / AIDS - Pipeline by Immuron Limited, H1 2015
HIV / AIDS - Pipeline by ImQuest Life Sciences, H1 2015
HIV / AIDS - Pipeline by InnaVirVax SA, H1 2015
HIV / AIDS - Pipeline by Inovio Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Japan Tobacco Inc., H1 2015
HIV / AIDS - Pipeline by Johnson & Johnson, H1 2015
HIV / AIDS - Pipeline by Kineta, Inc., H1 2015
HIV / AIDS - Pipeline by Laboratorios Del Dr. Esteve S.A., H1 2015
HIV / AIDS - Pipeline by Laila Pharmaceuticals Pvt. Ltd., H1 2015
HIV / AIDS - Pipeline by Longevity Biotech, Inc, H1 2015
HIV / AIDS - Pipeline by Medestea Research & Production S.p.A., H1 2015
HIV / AIDS - Pipeline by Medivir AB, H1 2015
HIV / AIDS - Pipeline by Merck & Co., Inc., H1 2015
HIV / AIDS - Pipeline by Mologen AG, H1 2015
HIV / AIDS - Pipeline by Mymetics Corporation, H1 2015
HIV / AIDS - Pipeline by Myrexis, Inc., H1 2015
HIV / AIDS - Pipeline by NanoBio Corporation, H1 2015
HIV / AIDS - Pipeline by NanoViricides, Inc., H1 2015
HIV / AIDS - Pipeline by Navigen Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by NeED Pharma s.r.l., H1 2015
HIV / AIDS - Pipeline by Nektar Therapeutics, H1 2015
HIV / AIDS - Pipeline by Novartis AG, H1 2015
HIV / AIDS - Pipeline by Omeros Corporation, H1 2015
HIV / AIDS - Pipeline by Omni Bio Pharmaceutical Inc., H1 2015
HIV / AIDS - Pipeline by Oncolys BioPharma Inc., H1 2015
HIV / AIDS - Pipeline by OncoNOx ApS, H1 2015
HIV / AIDS - Pipeline by Oncovir, Inc., H1 2015
HIV / AIDS - Pipeline by Orbis Biosciences, Inc., H1 2015
HIV / AIDS - Pipeline by Osel Inc., H1 2015
HIV / AIDS - Pipeline by OyaGen Inc., H1 2015
HIV / AIDS - Pipeline by PaxVax, H1 2015
HIV / AIDS - Pipeline by Pepscan Therapeutics, H1 2015
HIV / AIDS - Pipeline by Peregrine Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Pfizer Inc., H1 2015
HIV / AIDS - Pipeline by Pharis Biotec GmbH, H1 2015
HIV / AIDS - Pipeline by Phoenix Biotechnology, Inc., H1 2015
HIV / AIDS - Pipeline by Polymun Scientific Immunbiologische Forschung GmbH, H1 2015
HIV / AIDS - Pipeline by Presidio Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Profectus BioSciences, Inc., H1 2015
HIV / AIDS - Pipeline by Quantum Pharmaceuticals, H1 2015
HIV / AIDS - Pipeline by RAPID Pharmaceuticals AG, H1 2015
HIV / AIDS - Pipeline by Recombio S.L, H1 2015
HIV / AIDS - Pipeline by Rodos BioTarget GmbH, H1 2015
HIV / AIDS - Pipeline by Rottapharm SpA, H1 2015
HIV / AIDS - Pipeline by Sangamo BioSciences, Inc., H1 2015
HIV / AIDS - Pipeline by Sanofi, H1 2015
HIV / AIDS - Pipeline by Sanofi Pasteur SA, H1 2015
HIV / AIDS - Pipeline by SEEK Group, H1 2015
HIV / AIDS - Pipeline by Sequoia Pharmaceuticals, Inc., H1 2015
HIV / AIDS - Pipeline by Serometrix, LLC, H1 2015
HIV / AIDS - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., H1 2015
HIV / AIDS - Pipeline by SKAU Vaccines ApS, H1 2015
HIV / AIDS - Pipeline by Spider Biotech, H1 2015
HIV / AIDS - Pipeline by Starpharma Holdings Limited, H1 2015
HIV / AIDS - Pipeline by Sumagen Co., Ltd., H1 2015
HIV / AIDS - Pipeline by Taiga Biotechnologies, Inc., H1 2015
HIV / AIDS - Pipeline by TaiMed Biologics Inc., H1 2015
HIV / AIDS - Pipeline by Takara Bio Inc., H1 2015
HIV / AIDS - Pipeline by TAmiRNA GmbH, H1 2015
HIV / AIDS - Pipeline by TechnoVax, Inc., H1 2015
HIV / AIDS - Pipeline by TetraLogic Pharmaceuticals, H1 2015
HIV / AIDS - Pipeline by Teva Pharmaceutical Industries Limited, H1 2015
HIV / AIDS - Pipeline by Theraclone Sciences, Inc., H1 2015
HIV / AIDS - Pipeline by Theravectys S.A., H1 2015
HIV / AIDS - Pipeline by Tobira Therapeutics, Inc., H1 2015
HIV / AIDS - Pipeline by Transgene Biotek Limited, H1 2015
HIV / AIDS - Pipeline by TVAX Biomedical, Inc., H1 2015
HIV / AIDS - Pipeline by United Biomedical, Inc., H1 2015
HIV / AIDS - Pipeline by United Therapeutics Corporation, H1 2015
HIV / AIDS - Pipeline by Vaccibody AS, H1 2015
HIV / AIDS - Pipeline by VG Life Sciences, Inc., H1 2015
HIV / AIDS - Pipeline by Vichem Chemie Research Ltd., H1 2015
HIV / AIDS - Pipeline by ViiV Healthcare Limited, H1 2015
HIV / AIDS - Pipeline by Viriom Ltd., H1 2015
HIV / AIDS - Pipeline by ViroLogik GmbH, H1 2015
HIV / AIDS - Pipeline by ViroXis Corporation, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
HIV / AIDS Therapeutics - Recent Pipeline Updates, H1 2015
HIV / AIDS - Dormant Projects, H1 2015
HIV / AIDS - Dormant Projects (Contd..1), H1 2015
HIV / AIDS - Dormant Projects (Contd..2), H1 2015
HIV / AIDS - Dormant Projects (Contd..3), H1 2015
HIV / AIDS - Dormant Projects (Contd..4), H1 2015
HIV / AIDS - Dormant Projects (Contd..5), H1 2015
HIV / AIDS - Dormant Projects (Contd..6), H1 2015
HIV / AIDS - Dormant Projects (Contd..7), H1 2015
HIV / AIDS - Dormant Projects (Contd..8), H1 2015
HIV / AIDS - Dormant Projects (Contd..9), H1 2015
HIV / AIDS - Dormant Projects (Contd..10), H1 2015
HIV / AIDS - Dormant Projects (Contd..11), H1 2015
HIV / AIDS - Dormant Projects (Contd..12), H1 2015
HIV / AIDS - Dormant Projects (Contd..13), H1 2015
HIV / AIDS - Dormant Projects (Contd..14), H1 2015
HIV / AIDS - Dormant Projects (Contd..15), H1 2015
HIV / AIDS - Dormant Projects (Contd..16), H1 2015
HIV / AIDS - Dormant Projects (Contd..17), H1 2015
HIV / AIDS - Dormant Projects (Contd..18), H1 2015
HIV / AIDS - Dormant Projects (Contd..19), H1 2015
HIV / AIDS - Dormant Projects (Contd..20), H1 2015
HIV / AIDS - Dormant Projects (Contd..21), H1 2015
HIV / AIDS - Dormant Projects (Contd..22), H1 2015
HIV / AIDS - Dormant Projects (Contd..23), H1 2015
HIV / AIDS - Dormant Projects (Contd..24), H1 2015
HIV / AIDS - Dormant Projects (Contd..25), H1 2015
HIV / AIDS - Dormant Projects (Contd..26), H1 2015
HIV / AIDS - Dormant Projects (Contd..27), H1 2015
HIV / AIDS - Dormant Projects (Contd..28), H1 2015
HIV / AIDS - Dormant Projects (Contd..29), H1 2015
HIV / AIDS - Dormant Projects (Contd..30), H1 2015
HIV / AIDS - Dormant Projects (Contd..31), H1 2015
HIV / AIDS - Dormant Projects (Contd..32), H1 2015
HIV / AIDS - Dormant Projects (Contd..33), H1 2015
HIV / AIDS - Dormant Projects (Contd..34), H1 2015
HIV / AIDS - Dormant Projects (Contd..35), H1 2015
HIV / AIDS - Discontinued Products, H1 2015
HIV / AIDS - Discontinued Products (Contd..1), H1 2015
HIV / AIDS - Discontinued Products (Contd..2), H1 2015
HIV / AIDS - Discontinued Products (Contd..3), H1 2015
HIV / AIDS - Discontinued Products (Contd..4), H1 2015
HIV / AIDS - Discontinued Products (Contd..5), H1 2015
HIV / AIDS - Discontinued Products (Contd..6), H1 2015
List of Figures
Number of Products under Development for HIV / AIDS, H1 2015
Number of Products under Development for HIV / AIDS - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report